Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.310
-0.230 (-6.50%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Lantern Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-20.78-15.96-14.26-12.36-5.91
Upgrade
Depreciation & Amortization
0.020.170.150.10
Upgrade
Loss (Gain) From Sale of Investments
-0.4-0.180.70.22-
Upgrade
Stock-Based Compensation
0.731.071.190.961.19
Upgrade
Other Operating Activities
0.390.010.06-0.11-
Upgrade
Change in Accounts Payable
1.64-0.240.581.620.12
Upgrade
Change in Other Net Operating Assets
0.590.77-1.19-1.02-1.06
Upgrade
Operating Cash Flow
-17.81-14.35-12.77-10.59-5.65
Upgrade
Capital Expenditures
-0.01-0.02-0.03-0.02-0.02
Upgrade
Investment in Securities
3.38-0.910.21-19.52-
Upgrade
Investing Cash Flow
3.37-0.930.18-19.53-0.02
Upgrade
Short-Term Debt Issued
----0.17
Upgrade
Long-Term Debt Issued
----0.11
Upgrade
Total Debt Issued
----0.28
Upgrade
Short-Term Debt Repaid
-----0.17
Upgrade
Total Debt Repaid
-----0.17
Upgrade
Net Debt Issued (Repaid)
----0.11
Upgrade
Issuance of Common Stock
0.07-0.369.1426.3
Upgrade
Repurchase of Common Stock
--0.5-2.48-0.94-
Upgrade
Other Financing Activities
----4.78-2.75
Upgrade
Financing Cash Flow
0.07-0.5-2.1863.4223.66
Upgrade
Foreign Exchange Rate Adjustments
-0.05-0.03-0.010-
Upgrade
Net Cash Flow
-14.43-15.81-14.7833.318
Upgrade
Free Cash Flow
-17.83-14.37-12.8-10.61-5.67
Upgrade
Free Cash Flow Per Share
-1.66-1.32-1.18-0.97-1.32
Upgrade
Levered Free Cash Flow
-11.44-8.7-8.68-5.56-3.46
Upgrade
Unlevered Free Cash Flow
-11.44-8.7-8.68-5.56-3.46
Upgrade
Change in Net Working Capital
-2.44-1.250.96-0.640.94
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q